Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...

Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoirData on the ...

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only ...

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only Safe ...

The types of Ebola and hantavirus panicking officials are very different from the species identified decades ago, raising new ...

ORLANDO, Fla. — The Florida Department of Health held its first public workshop Friday on the subject of changing state rules regarding vaccines. It’s part of an ongoing push led by the state’s ...

Science and art have been brought together in a series of new projects led by a Kingston University London academic, ...